Contrast-enhanced ultrasound predicts microvascular invasion in patients with hepatocellular carcinoma
Jing-Yuan Huang a , ∗, Zhi-Liang Huang a , Zhe Yang b , Xiao-Ping Zheng c
a Department of Ultrasound, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310022, China
b Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310022, China
c Department of Pathology, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310022,
China
Abstract：The presence of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is an important indicator for HCC recurrence and poor prognosis [1]. Determining the preoperative MVI status is helpful for guiding clinical treatment and improving prognosis. Currently, MVI diagnosis is achieved primarily by postoperative histopathology, which makes it difficult to provide a definite diagnosis before surgery. However, significant advancements in imaging technology have begun to allow clinicians to make a diagnosis of HCC MVI prior to surgery. In this study, we used contrastenhanced ultrasound (CEUS) to observe the characteristics of HCC enhancement patterns and quantitatively analyze the changes in HCC blood perfusion parameters to explore the value of CEUS in evaluating HCC MVI.
2022, Vol. 21 
